Cargando…
Stereoisomerism of stapled peptide inhibitors of the p53-Mdm2 interaction: an assessment of synthetic strategies and activity profiles
All-hydrocarbon, i, i+7 stapled peptide inhibitors of the p53-Mdm2 interaction have emerged as promising new leads for cancer therapy. Typical chemical synthesis via olefin metathesis results in the formation of both E- and Z-isomers, an observation that is rarely disclosed but may be of importance...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610352/ https://www.ncbi.nlm.nih.gov/pubmed/31316744 http://dx.doi.org/10.1039/c9sc01456j |
_version_ | 1783432490451468288 |
---|---|
author | Yuen, Tsz Ying Brown, Christopher J. Xue, Yuezhen Tan, Yaw Sing Ferrer Gago, Fernando J. Lee, Xue Er Neo, Jin Yong Thean, Dawn Kaan, Hung Yi Kristal Partridge, Anthony W. Verma, Chandra S. Lane, David P. Johannes, Charles W. |
author_facet | Yuen, Tsz Ying Brown, Christopher J. Xue, Yuezhen Tan, Yaw Sing Ferrer Gago, Fernando J. Lee, Xue Er Neo, Jin Yong Thean, Dawn Kaan, Hung Yi Kristal Partridge, Anthony W. Verma, Chandra S. Lane, David P. Johannes, Charles W. |
author_sort | Yuen, Tsz Ying |
collection | PubMed |
description | All-hydrocarbon, i, i+7 stapled peptide inhibitors of the p53-Mdm2 interaction have emerged as promising new leads for cancer therapy. Typical chemical synthesis via olefin metathesis results in the formation of both E- and Z-isomers, an observation that is rarely disclosed but may be of importance in targeting PPI. In this study, we evaluated the effect of staple geometry on the biological activity of five p53-reactivating peptides. We also present strategies for the modulation of the E/Z ratio and attainment of the hydrogenated adduct through repurposing of the metathesis catalyst. |
format | Online Article Text |
id | pubmed-6610352 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Royal Society of Chemistry |
record_format | MEDLINE/PubMed |
spelling | pubmed-66103522019-07-15 Stereoisomerism of stapled peptide inhibitors of the p53-Mdm2 interaction: an assessment of synthetic strategies and activity profiles Yuen, Tsz Ying Brown, Christopher J. Xue, Yuezhen Tan, Yaw Sing Ferrer Gago, Fernando J. Lee, Xue Er Neo, Jin Yong Thean, Dawn Kaan, Hung Yi Kristal Partridge, Anthony W. Verma, Chandra S. Lane, David P. Johannes, Charles W. Chem Sci Chemistry All-hydrocarbon, i, i+7 stapled peptide inhibitors of the p53-Mdm2 interaction have emerged as promising new leads for cancer therapy. Typical chemical synthesis via olefin metathesis results in the formation of both E- and Z-isomers, an observation that is rarely disclosed but may be of importance in targeting PPI. In this study, we evaluated the effect of staple geometry on the biological activity of five p53-reactivating peptides. We also present strategies for the modulation of the E/Z ratio and attainment of the hydrogenated adduct through repurposing of the metathesis catalyst. Royal Society of Chemistry 2019-05-30 /pmc/articles/PMC6610352/ /pubmed/31316744 http://dx.doi.org/10.1039/c9sc01456j Text en This journal is © The Royal Society of Chemistry 2019 https://creativecommons.org/licenses/by-nc/3.0/This article is freely available. This article is licensed under a Creative Commons Attribution Non Commercial 3.0 Unported Licence (CC BY-NC 3.0) |
spellingShingle | Chemistry Yuen, Tsz Ying Brown, Christopher J. Xue, Yuezhen Tan, Yaw Sing Ferrer Gago, Fernando J. Lee, Xue Er Neo, Jin Yong Thean, Dawn Kaan, Hung Yi Kristal Partridge, Anthony W. Verma, Chandra S. Lane, David P. Johannes, Charles W. Stereoisomerism of stapled peptide inhibitors of the p53-Mdm2 interaction: an assessment of synthetic strategies and activity profiles |
title | Stereoisomerism of stapled peptide inhibitors of the p53-Mdm2 interaction: an assessment of synthetic strategies and activity profiles
|
title_full | Stereoisomerism of stapled peptide inhibitors of the p53-Mdm2 interaction: an assessment of synthetic strategies and activity profiles
|
title_fullStr | Stereoisomerism of stapled peptide inhibitors of the p53-Mdm2 interaction: an assessment of synthetic strategies and activity profiles
|
title_full_unstemmed | Stereoisomerism of stapled peptide inhibitors of the p53-Mdm2 interaction: an assessment of synthetic strategies and activity profiles
|
title_short | Stereoisomerism of stapled peptide inhibitors of the p53-Mdm2 interaction: an assessment of synthetic strategies and activity profiles
|
title_sort | stereoisomerism of stapled peptide inhibitors of the p53-mdm2 interaction: an assessment of synthetic strategies and activity profiles |
topic | Chemistry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610352/ https://www.ncbi.nlm.nih.gov/pubmed/31316744 http://dx.doi.org/10.1039/c9sc01456j |
work_keys_str_mv | AT yuentszying stereoisomerismofstapledpeptideinhibitorsofthep53mdm2interactionanassessmentofsyntheticstrategiesandactivityprofiles AT brownchristopherj stereoisomerismofstapledpeptideinhibitorsofthep53mdm2interactionanassessmentofsyntheticstrategiesandactivityprofiles AT xueyuezhen stereoisomerismofstapledpeptideinhibitorsofthep53mdm2interactionanassessmentofsyntheticstrategiesandactivityprofiles AT tanyawsing stereoisomerismofstapledpeptideinhibitorsofthep53mdm2interactionanassessmentofsyntheticstrategiesandactivityprofiles AT ferrergagofernandoj stereoisomerismofstapledpeptideinhibitorsofthep53mdm2interactionanassessmentofsyntheticstrategiesandactivityprofiles AT leexueer stereoisomerismofstapledpeptideinhibitorsofthep53mdm2interactionanassessmentofsyntheticstrategiesandactivityprofiles AT neojinyong stereoisomerismofstapledpeptideinhibitorsofthep53mdm2interactionanassessmentofsyntheticstrategiesandactivityprofiles AT theandawn stereoisomerismofstapledpeptideinhibitorsofthep53mdm2interactionanassessmentofsyntheticstrategiesandactivityprofiles AT kaanhungyikristal stereoisomerismofstapledpeptideinhibitorsofthep53mdm2interactionanassessmentofsyntheticstrategiesandactivityprofiles AT partridgeanthonyw stereoisomerismofstapledpeptideinhibitorsofthep53mdm2interactionanassessmentofsyntheticstrategiesandactivityprofiles AT vermachandras stereoisomerismofstapledpeptideinhibitorsofthep53mdm2interactionanassessmentofsyntheticstrategiesandactivityprofiles AT lanedavidp stereoisomerismofstapledpeptideinhibitorsofthep53mdm2interactionanassessmentofsyntheticstrategiesandactivityprofiles AT johannescharlesw stereoisomerismofstapledpeptideinhibitorsofthep53mdm2interactionanassessmentofsyntheticstrategiesandactivityprofiles |